YC1 displayed excellent anti-cancer effects in different cancer cells including lung cancer, bladder cancer, breast cancer, canine lymphoma, colorectal cancer, gastric carcinoma, hepatocellular carcinoma cancer (HCC), preeclampsia, ovarian cancer, and non-small cell lung cancer (NSCLC) [200]. This evidence concerns the gene RBMS1 and cancer.